Evoke Pharma, Inc. (EVOK)

Market Cap	10.37M
Revenue (ttm)	11.59M
Net Income (ttm)	-5.08M
Shares Out	2.02M
EPS (ttm)	-2.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	237,023
Open	5.58
Previous Close	5.74
Day's Range	4.92 - 5.58
52-Week Range	1.94 - 12.32
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2025

About EVOK

Evoke Pharma, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is based in Solana Beach, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Sep 25, 2013
• Employees: 3
• Stock Exchange: NASDAQ
• Ticker Symbol: EVOK
• Website: https://www.evokepharma.com

Financial Performance

In 2024, Evoke Pharma's revenue was $10.25 million, an increase of 97.84% compared to the previous year's $5.18 million. Losses were -$5.35 million, -31.31% less than in 2023.